CYTENA
Dominik Bernhardt has a diverse work experience spanning several companies and roles. Dominik'smost recent position is as the Director of R&D at CYTENA, starting in December 2022. Prior to this, they held the role of Head of Software at CYTENA from June 2021 to December 2022.
Before joining CYTENA, Dominik worked at Stryker from 2013 to 2021, where they had various roles. Dominik served as the Manager of Software Development from July 2015 to May 2021, and as a Senior Domain Engineer from March 2013 to June 2015.
Additionally, Dominik worked at Siemens Healthcare from 2007 to 2013, where they held the position of Head of Algorithm Predevelopment and Prototyping of CT Postprocessing Applications from August 2012 to February 2013. Prior to this, they served as the Scientific Lead for Clinical Applications from May 2007 to August 2012.
Dominik's career began at the Karlsruhe Institute of Technology (KIT) / University of Karlsruhe (TH) in 2004, where they worked as a Research Assistant from September 2004 to May 2007.
Dominik Bernhardt earned their first degree, a Dipl.-Inform., in Informatik from the Karlsruhe Institute of Technology (KIT) in 2004. Dominik continued their education at KIT and obtained a Dr.-Ing. degree in Informatik in 2009.
CYTENA
cytena GmbH has developed a device called cy-Clone to separate single cells. Single cells are required for the development of state-of-the-art drugs, so-called biologicals as well as for the genetic analysis of single cells for cancer and stem cell research. The cy-Clone is supported by an automated imaging process to encapsulate cells indroplets, which are delivered to any type of substrate. Thanks to this particularly gentle delivery method, the cells are able to survive post printing and can either be analyzed thereafter or grown into clonal colonies. To determine clonality, multiple images are recorded during the process. Cross-contamination is avoided by the use of disposable parts.